Allumiqs (formerly PhenoSwitch Bioscience) is a tech-driven CRO at the forefront of multiomics research, specializing in proteomics, metabolomics, lipidomics, and small molecule analysis powered by advanced mass spectrometry. From our state-of-the-art labs in Sherbrooke, QC, and Halifax, NS, we deliver precise, high-impact data that helps biopharma and life sciences companies fast-track discoveries and bring innovations to market.

As one of the first CROs to develop Data Independent Acquisition (DIA) mass spectrometry methods and applications, we set the standard for comprehensive quantification in untargeted workflows across proteins, metabolites, and lipids. Leveraging our extensive experience from thousands of successful projects, our scientific team has developed a robust suite of bioinformatics tools to streamline data processing, statistical analysis, and reporting.

Our expertise in integrating diverse data sources—like proteomics and metabolomics with external datasets such as genomics—allows us to identify and highlight critical features that differentiate conditions, enabling breakthrough insights in biomarker discovery, patient stratification, and mechanism of action (MOA) research.

Collaborating with Allumiqs means working with a dedicated team of scientists who deliver in-depth analyses with speed and precision, following proven operational guidelines.

Bold Science. Beyond Data. Better Together.

Media

---